2022
Exports | Imports
$10.3M | $774MWorld Rnk 73 / 208
Flag Rnk 237 / 1142
World Rnk 44 / 225
Flag Rnk 14 / 1203
2022
ECONOMIC COMPLEXITY of Chile
-0.22Rnk 71 / 124
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.47Rnk 46 / 1025

About

Exports In 2022, Chile exported $10.3M in Vaccines, blood, antisera, toxins and cultures, making it the 73rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 237th most exported product in Chile. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Chile are: Colombia ($1.9M), Argentina ($1.77M), Costa Rica ($1.18M), France ($873k), and Peru ($716k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Chile between 2021 and 2022 were Costa Rica ($984k), Argentina ($915k), and Colombia ($614k).

Imports In 2022, Chile imported $774M in Vaccines, blood, antisera, toxins and cultures, becoming the 44th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 14th most imported product in Chile. Chile imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($190M), Belgium ($166M), Switzerland ($96.3M), Ireland ($66.1M), and Norway ($52.1M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Chile between 2021 and 2022 were Belgium ($122M), Ireland ($49.5M), and Switzerland ($22.4M).

COMPANIES In 2023, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Chile to the United States.

Latest Trends

January 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (January 2023 - January 2024)$-306k(-58.6%)
IMPORT GROWTH (January 2023 - January 2024)$14.8M(32.8%)
MAIN EXPORTER (January 2024)San Carlos$152k
MAIN DESTINATION (January 2024)Argentina$181k

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Chile. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$10.3M
IMPORTS (2022)$774M
NET TRADE (2022)-$763M

In 2022, Chile exported $10.3M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Chile exports on Vaccines, blood, antisera, toxins and cultures were Colombia ($1.9M), Argentina ($1.77M), Costa Rica ($1.18M), France ($873k), and Peru ($716k).

In 2022, Chile imported $774M in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($190M), Belgium ($166M), Switzerland ($96.3M), Ireland ($66.1M), and Norway ($52.1M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Chile WERE (2021 - 2022):
Costa Rica$984k (497%)
Argentina$915k (107%)
Colombia$614k (47.9%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Chile WERE (2021 - 2022):
France-$418k (-32.4%)
United Arab Emirates-$41.4k (-99.1%)
Venezuela-$33.2k (-100%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Chile's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Chile's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with